Published in Br Med J (Clin Res Ed) on September 19, 1987
Ciprofloxacin safety in paediatrics: a systematic review. Arch Dis Child (2011) 1.07
Comparison of single-dose treatment with norfloxacin and standard 5-day treatment with trimethoprim-sulfamethoxazole for acute shigellosis in adults. Antimicrob Agents Chemother (1989) 0.94
Bone age, social deprivation, and single parent families. Arch Dis Child (1992) 0.87
[Cartilage-damaging effect of quinolones]. Infection (1991) 0.77
Fluoroquinolone use in a child associated with development of osteochondritis dissecans. BMJ Case Rep (2014) 0.75
An update on drug-induced arthritis. Rheumatol Int (2016) 0.75
Distribution of rheumatoid factor activity in nonrheumatoid states. Ann N Y Acad Sci (1969) 2.35
Oral ciprofloxacin compared with conventional intravenous treatment for Pseudomonas aeruginosa infection in adults with cystic fibrosis. Lancet (1987) 1.66
Pathogenesis and management of arthropathy in cystic fibrosis. J R Soc Med (1986) 1.48
Elective versus symptomatic antibiotic treatment in cystic fibrosis patients with chronic Pseudomonas infection of the lungs. Thorax (2000) 2.31
Cystic fibrosis and coeliac disease: coexistence in two children. Arch Dis Child (1973) 1.80
Pancreatic enzyme supplement dosage in cystic fibrosis. Lancet (1991) 1.64
Neonatal screening for cystic fibrosis in Wales and the West Midlands: clinical assessment after five years of screening. Arch Dis Child (1991) 1.52
Defective beta-adrenergic secretory responses in submandibular acinar cells from cystic fibrosis patients. Lancet (1986) 1.23
Attitudes of parents of cystic fibrosis children towards neonatal screening and antenatal diagnosis. Clin Genet (1990) 1.20
Aspects of bile acid metabolism in cystic fibrosis. Arch Dis Child (1975) 1.18
Hepatic dysfunction in association with pancreatic insufficiency and cyclical neutropenia. Shwachman-Diamond syndrome. Arch Dis Child (1977) 1.17
Transmission of Pseudomonas cepacia among cystic fibrosis patients. Lancet (1992) 1.13
Albumin inhibits human polymorphonuclear leucocyte luminol-dependent chemiluminescence: evidence for oxygen radical scavenging. Br J Exp Pathol (1984) 1.12
Neonatal screening for cystic fibrosis in Wales and the West Midlands: 1. Evaluation of immunoreactive trypsin test. J Clin Pathol (1988) 1.08
Severity of chest disease in cystic fibrosis patients in relation to their genotypes. J Med Genet (1992) 1.06
Deposition of eosinophil cationic protein in granulomas in allergic granulomatosis and vasculitis: the Churg-Strauss syndrome. Br Med J (Clin Res Ed) (1984) 1.06
Cystic fibrosis-related deaths in infancy and the effect of newborn screening. Pediatr Pulmonol (2001) 1.00
A search for linkage in cystic fibrosis. J Med Genet (1976) 0.99
Transmission and prevalence of Burkholderia cepacia in Welsh cystic fibrosis patients. Respir Med (1998) 0.98
The biochemical defect in cystic fibrosis. Clin Sci (Lond) (1988) 0.97
Cystic fibrosis in 3 Pakistani children. Arch Dis Child (1974) 0.95
Mortality from leukaemia among relatives of patients with cystic fibrosis. BMJ (1989) 0.93
Vitamin A absorption in cystic fibrosis: risk of hypervitaminosis A. Gut (1992) 0.93
Methimazole and generation of oxygen radicals by monocytes: potential role in immunosuppression. Br Med J (Clin Res Ed) (1984) 0.92
Manubrio-sternal joint subluxation in rheumatoid arthritis. J Rheumatol (1980) 0.91
Attendance allowance for patients with cystic fibrosis. BMJ (1991) 0.90
Leukaemia mortality among relatives of cystic fibrosis patients. Arch Dis Child (1991) 0.89
Liver scans in cystic fibrosis. Arch Dis Child (1975) 0.89
Ciprofloxacin therapy in cystic fibrosis. J Antimicrob Chemother (1987) 0.87
Two CF patients, one homozygous for the 621 + 1G > T splice mutation, the other homozygous for the 1898 + 1G > A splice mutation. J Med Genet (1995) 0.84
Direct sequencing of the complete CFTR gene: the molecular characterisation of 99.5% of CF chromosomes in Wales. Hum Mol Genet (1993) 0.84
Comparative trial of pancrex V forte and nutrizym in treatment of malabsorption in cystic fibrosis. Br Med J (1974) 0.84
Cystic fibrosis serum stimulates mucin secretion but not calcium efflux from rat submandibular acini. Clin Chim Acta (1983) 0.84
An altered calmodulin binding protein in cystic fibrosis--a clue to the biochemical defect. Clin Chim Acta (1988) 0.83
Adrenergic secretory responses of submandibular tissues from control subjects and cystic fibrosis patients. Clin Chim Acta (1985) 0.83
Screening for cystic fibrosis. Br Med Bull (1992) 0.82
Cystic fibrosis, pancreatic sufficiency and distal intestinal obstruction syndrome: a report of four cases. Acta Paediatr (1995) 0.80
Electrolyte concentrations in control and cystic fibrosis submandibular saliva. Biochem Soc Trans (1990) 0.79
Practical management of nutrition and gastrointestinal tract in cystic fibrosis. J R Soc Med (1986) 0.79
Defective regulation of electrolyte and protein secretion in submandibular saliva of cystic fibrosis patients. Acta Paediatr Scand (1991) 0.79
Maintenance of growth in cystic fibrosis despite reduction in pancreatic enzyme supplementation. Arch Dis Child (1998) 0.77
Nutritional management of cystic fibrosis. Digestion (1987) 0.77
Examination of submandibular fluid in cystic fibrosis. Acta Univ Carol Med (Praha) (1990) 0.77
Increased susceptibility to peroxide-induced haemolysis with normal vitamin E concentrations in cystic fibrosis. Clin Chim Acta (1991) 0.77
Paradoxical effects of essential fatty acid supplementation on lipid profiles and sweat electrolytes in cystic fibrosis. Br J Nutr (1990) 0.76
Biochemical basis of cystic fibrosis. Nature (1986) 0.76
Insulin excretion in cystic fibrosis. Arch Dis Child (1972) 0.75
Defective phosphorylation of a calmodulin-binding protein in cystic-fibrosis submandibular glands. Biochem J (1989) 0.75
Familial pancreatic enzyme insufficiency. Arch Dis Child (1992) 0.75
Sequential serological responses to Aspergillus fumigatus in patients with cystic fibrosis. Use of antigen 'stretching' to delineate IgG and IgE activity. Clin Exp Immunol (1990) 0.75
Inhibition of sugar transport by plasma from cystic-fibrosis patients. Lancet (1971) 0.75
Increased phosphoinositide breakdown by phospholipase C in erythrocyte membranes from patients with cystic fibrosis. Clin Chim Acta (1989) 0.75
Actions of isoprenaline on amylase and total protein content of whole saliva in control, cystic fibrosis and cystic fibrosis heterozygote individuals. Acta Paediatr (1994) 0.75
Dietary management of cystic fibrosis. Practitioner (1981) 0.75
Postprandial total serum bile acid concentrations in cystic fibrosis. Monogr Paediatr (1979) 0.75
Total involvement: nursing care and evaluation in a cancer hospital. QRB Qual Rev Bull (1978) 0.75
Attitudes of parents of cystic fibrosis children towards neonatal screening and antenatal diagnosis. Adv Exp Med Biol (1991) 0.75
Decaying town centres-- conservation or redevelopment? Environmental management objectives. R Soc Health J (1976) 0.75
Altered calmodulin activity in buccal epithelial cells from cystic fibrosis patients. Clin Chim Acta (1987) 0.75
Prostaglandins and cystic fibrosis. Monogr Paediatr (1979) 0.75
Enzyme contents of pancreatic extract preparations. Are they optimal? Drugs (1992) 0.75
Altered biochemical regulation of secretion in cystic fibrosis epithelial cells. Adv Exp Med Biol (1991) 0.75
An altered phosphoprotein in cystic fibrosis. Acta Univ Carol Med (Praha) (1990) 0.75
Luminol dependent chemiluminescence and thiol group oxidation provoked by neutrophils is attributable to different oxidizing species. J Biolumin Chemilumin (1987) 0.75
Erythrocyte membrane properties in cystic fibrosis. Clin Chim Acta (1974) 0.75
Inhibition of sugar transport by cystic fibrosis plasma. Gut (1971) 0.75
Dislocation of the manubriosternal joint: detection on frontal chest radiographs. Br J Radiol (1988) 0.75
Homoeopathy in childbearing. Midwives Chron (1988) 0.75
Peripheral long lines in cystic fibrosis. J Clin Pharm Ther (1997) 0.75